Raymond Uyiosa Osarogiagbon, MD, FACP, is an active practicing hematologist/medical oncologist at the Baptist Cancer Center in Memphis, Tennessee, an American College of Surgeons Commission on Cancer (CoC)-accredited Comprehensive Community Cancer Center. He serves as Director of the Thoracic Oncology Research Group and the Multidisciplinary Thoracic Oncology Program at the Baptist Cancer Center. Additionally, he is Research Professor at the University of Memphis School of Public Health in Memphis, and a member of the Vanderbilt Ingram Cancer Center in Nashville, Tennessee.
His research focuses on improving healthcare systems, including examination of oncology care delivery models, quantifying the relative survival impact of determinants of quality care in thoracic oncology, and improving the quality of surgical resection and pathologic staging of lung cancer. Current research support includes R01 funding from the National Cancer Institute (NCI) and the Patient-Centered Outcomes Research Institute (PCORI). He is also the Principal Investigator of the Baptist Cancer Center/Mid-South Minority-Underserved National Cancer Institute Community Oncology Research Program (NCORP).
Dr. Osarogiagbon is a member of the Alpha Omega Alpha Honor Medical Society (AOA), the American Society of Clinical Oncology (ASCO) Workforce Advisory Group, the National Institutes of Health’s Health Services Organization and Delivery (HSOD) Study Section, and the Board of Directors of the Bonnie J. Addario Lung Cancer Foundation’s Center of Excellence Program. He is also on the editorial boards of the journals Translational Lung Cancer Research and Journal of Thoracic Diseases, as well as the Chairman-Elect of the International Association for the Study of Lung Cancer (IASLC) Membership Committee.
He received his medical degree from the University of Ibadan, Nigeria, and completed Internal Medicine Residency training at Texas Tech University Health Sciences Center in and a Fellowship in Hematology and Medical Oncology at the University of Minnesota.